Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Automated Rx Dispensing Used By 10% Of Independent Pharmacies – NCPA

  • News

Executive Summary

Automated prescription dispensing systems are used in 10% of independent retail pharmacies, preliminary data from the 2002 NCPA-Pharmacia Digest show

You may also be interested in...



ABCs Of Bar-Coding: AmerisourceBergen Buying Bridge Medical

AmerisourceBergen is investing $27 mil. in medication error prevention services through the acquisition of Bridge Medical, Inc

ABCs Of Bar-Coding: AmerisourceBergen Buying Bridge Medical

AmerisourceBergen is investing $27 mil. in medication error prevention services through the acquisition of Bridge Medical, Inc

Mail-Order Pharmacy Sales Continue 25% Annual Growth, NACDS Report Says

Mail-order pharmacy sales continue to grow at an annual rate of about 25%, according to data in the National Association of Chain Drug Stores' 2002 Chain Pharmacy Industry Profile

Table

View full table

Related Content

Pink Sheet
Tags:
Latest Headlines

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

See All
UsernamePublicRestriction

Register

PS040104

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By